What is the primary purpose of this 8-K filing?

This 8-K filing primarily serves to report key events and agreements related to HCA Healthcare's completion of its initial public offering (IPO) on March 15, 2011. It details crucial corporate governance changes, investor agreements, and the financial outcomes of the IPO.

What is the significance of the Stockholders' Agreement?

The Stockholders' Agreement is significant because it outlines the ongoing rights and influence of major investors like Bain Capital, KKR, BAML, and the Frist Entities. It grants them consent rights over substantial corporate decisions and the ability to nominate directors, indicating their continued material interest and involvement in the company's strategic direction post-IPO.

What happened to the management agreement with the investors?

The management agreement that the investors had with HCA Inc. terminated as per its terms upon the completion of the IPO. The investors and certain Frist family members received a final fee of approximately $211 million in connection with this termination.

What were the key changes to HCA's capital structure and governance documents?

HCA's Amended and Restated Certificate of Incorporation and Bylaws became effective. These changes included a stock split (4.505 shares for each existing share), an increase in the number of authorized shares of common and preferred stock, and modifications to the procedures for shareholder actions and bylaw amendments, with a higher threshold required for bylaw changes once the initial majority investor's stake decreases.

HCA 8-K: Leadership Changes, Material Agreements & More

Summary

This 8-K filing by HCA Healthcare, Inc. (HCA), filed on March 16, 2011, details significant corporate actions surrounding its initial public offering (IPO). A key event is the entry into a Stockholders’ Agreement on March 9, 2011, which governs the rights and obligations of major investors, including Bain Capital, KKR, BAML, and the Frist Entities. This agreement grants these investors consent rights over significant corporate actions and nomination rights for board directors and committee members. The filing also announces the termination of a prior management agreement with these investors, with a final fee of approximately $211 million paid. Concurrently, HCA implemented significant changes to its corporate structure and governance, including the effectiveness of its Amended and Restated Certificate of Incorporation and Bylaws. These amendments involved a 1-for-4.505 stock split, an increase in authorized shares, and modifications to the procedures for amending bylaws, particularly concerning the voting power of majority stockholders. The report confirms the completion of the IPO on March 15, 2011, where HCA sold shares for approximately $2.5 billion in net proceeds, with selling stockholders realizing an additional $1.7 billion.

Key Highlights

1HCA completed its Initial Public Offering (IPO) on March 15, 2011, selling approximately 87.7 million shares for the company and 57.4 million shares for selling stockholders, raising substantial capital.
2A new Stockholders’ Agreement was established on March 9, 2011, defining rights for major investors (Bain Capital, KKR, BAML, Frist Entities) concerning corporate actions and board nominations.
3The termination of a previous management agreement with investors occurred upon the IPO completion, with a final payment of approximately $211 million made.
4HCA's Amended and Restated Certificate of Incorporation became effective, featuring a 1-for-4.505 stock split and increasing authorized shares to 1.8 billion common and 200 million preferred.
5Amendments to the Company's Bylaws were enacted, modifying procedures for stockholder nominations and proposals, and altering the voting threshold for future bylaw amendments.
6Two new directors, Jay O. Light and Geoffrey G. Meyers, were appointed to the Board of Directors, also joining the Audit and Compliance and Compensation Committees.
7The Company's 2006 Stock Incentive Plan was amended and restated, increasing the authorized shares for awards by 40 million.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Mar 16, 2011)

Summary

Key Highlights

Frequently Asked Questions